Empowering Diversity in Clinical Trials for Enhanced Health Outcomes
November 27, 2025
In a world of drug tests, trials must show all lives. Experts
- March 12, 2026
Medical affairs, MSLs, and clinical communication
In a world of drug tests, trials must show all lives. Experts
Bayer’s recent Phase 3 clinical trial for its innovative blood-thinner, asundexian, has
The landscape of Alzheimer’s treatment took a notable downturn recently when Johnson
Bayer has recently made headlines in the biopharma sector with groundbreaking results
Agios Pharmaceuticals recently faced a tumultuous period as its stock value took
In a significant turn of events, Ensoma, a Boston-based biotechnology startup dedicated
Agios Pharmaceuticals recently faced a substantial decline in its stock value following
In a bold move aimed at revitalizing American pharmaceutical research, FDA Commissioner
In the bustling landscape of breast cancer treatments, Roche’s giredestrant has emerged
In a significant shift in the biopharmaceutical landscape, Bristol Myers Squibb and
Neurocrine Biosciences is experiencing a rollercoaster moment in the biopharma sector with
Neurocrine Biosciences, a prominent player in the biotechnology sector, recently faced a
Cogent Biosciences is making waves in the biopharmaceutical industry following the remarkable
As the field of biopharma continues to innovate and advance, Roche has
In a groundbreaking clinical trial conducted in China, the innovative drug ivonescimab
In a surprising turn of events, UniQure, a prominent player in the
In a significant stride toward transforming the treatment landscape for rare endocrine
In recent weeks, Alto Neuroscience has witnessed a remarkable surge in its
The Congressional Budget Office (CBO) made headlines with its recent announcement about
In the fast-paced world of biopharma, staying informed about the latest trends
